Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression

Ianire Astobiza1,2, Catalina Capó-Serra3, Cristina Viera1

  • 1Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Derio, Spain.

Nature Communications
|June 16, 2026
PubMed

Insights

Aspartoacylase (ASPA) is repressed in cancer stroma, hindering fibroblast function. Restoring ASPA inhibits cancer progression by blocking Transforming Growth Factor Beta (TGFβ) signaling and pro-tumoral responses.

Area of Science:

  • Oncology
  • Cancer Biology
  • Metabolic Pathways

Background:

  • Cancer metabolic reprogramming focuses on tumor cells, neglecting stromal cell adaptations.
  • Stromal cells, including cancer-associated fibroblasts (CAFs), play crucial roles in tumor microenvironment.
  • The metabolic adaptations of stromal cells in cancer remain understudied.

Purpose of the Study:

  • To investigate the role of metabolic enzyme aspartoacylase (ASPA) in cancer stroma.
  • To elucidate the relationship between ASPA and Transforming Growth Factor Beta (TGFβ) signaling in fibroblasts.
  • To determine the prognostic value of ASPA in human cancer specimens.

Main Methods:

  • Identification of ASPA as a repressed enzyme in tumor stroma and CAFs.
  • Experimental analysis of the crosstalk between ASPA and TGFβ signaling in fibroblasts.
  • Correlation analysis of ASPA expression with TGFβ levels and clinical outcomes in human cancer samples.

Main Results:

  • ASPA is consistently repressed in tumor stroma and CAFs.
  • A reciprocal crosstalk exists: TGFβ suppresses ASPA, while ASPA restrains TGFβ-driven fibroblast activation.
  • ASPA restrains myofibroblast conversion, ECM remodeling, angiogenesis, and pro-tumoral macrophage phenotypes.
  • Low ASPA expression is a negative prognostic marker in various cancers, linked to high TGFβ signaling and aggressive tumor features.

Conclusions:

  • ASPA acts as a crucial regulator of fibroblast behavior within the tumor microenvironment.
  • ASPA functions as a gatekeeper against TGFβ-induced cancer progression.
  • Targeting ASPA or its regulatory pathways may offer novel therapeutic strategies for cancer treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...